you are here: Home News Dr Reddy Laboratories

Dr Reddy Laboratories

Dr Reddy’s denies report of cutting workforce costs by 25%, calls in 'factually incorrect'
CLSA selects Apollo Hospitals as top pick, says India's pharma set to outpace US growth
Dr Reddy's Q2 results: Net profit falls 15% to Rs 1,255 crore
Why everyone is not convinced about Dr Reddy’s latest acquisition
Nestle India, Dr Reddy's to form JV for nutraceutical brands in India, other agreed territories
Pharma Sector set for gains: Dr Reddy's Lab sees significant long position build-up
Torrent Pharma acquires four brands from Dr Reddy’s Lab
Dr Reddy’s Q2 Results Preview: Revenue expected to increase 4-5%, PAT to decline 15%
Dr Reddy's looks to cut greenhouse gas emissions by 55 percent in 10 years
Dr Reddy's Labs sells rights of cloderm cream to EPI Health LLC
Dr Reddy's arm sells specialty skin cream Cloderm to EPI Health
Markets@Moneycontrol: Nifty likely to open higher; top 3 stocks which could give 7-9% return
Dr.Reddys bullish about better sales in Europe in FY19
Dr Reddy's recalls over 80,000 bottles of Atorvastatin from US
New draft pharma policy will reduce risks like generalisation of mkt: JM Financial
Dr Reddy's likely to divest Penicillin assets in US: Sources
US law firm files class action lawsuit against Dr Reddy's for misleading statements
Hold Dr Reddy's Laboratories; target of Rs 2450: Axis Direct
What's In A Name? Registration of surnames as trademark
Hold Dr Reddys Laboratories: Ventura Securities
Kronos Drives Workforce Compliance And Productivity At Dr. Reddy's
Unsure of how biz will shape up in German mkt: Dr Reddy's

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Dr Reddy Laboratories

Dr Reddy’s denies report of cutting workforce costs by 25%, calls in 'factually incorrect'

CLSA selects Apollo Hospitals as top pick, says India's pharma set to outpace US growth

Dr Reddy's Q2 results: Net profit falls 15% to Rs 1,255 crore

Why everyone is not convinced about Dr Reddy’s latest acquisition

Nestle India, Dr Reddy's to form JV for nutraceutical brands in India, other agreed territories

Pharma Sector set for gains: Dr Reddy's Lab sees significant long position build-up

Torrent Pharma acquires four brands from Dr Reddy’s Lab

Dr Reddy’s Q2 Results Preview: Revenue expected to increase 4-5%, PAT to decline 15%

Dr Reddy's looks to cut greenhouse gas emissions by 55 percent in 10 years

Dr Reddy's Labs sells rights of cloderm cream to EPI Health LLC

Dr Reddy's arm sells specialty skin cream Cloderm to EPI Health

Markets@Moneycontrol: Nifty likely to open higher; top 3 stocks which could give 7-9% return

Dr.Reddys bullish about better sales in Europe in FY19

Dr Reddy's recalls over 80,000 bottles of Atorvastatin from US

New draft pharma policy will reduce risks like generalisation of mkt: JM Financial

Dr Reddy's likely to divest Penicillin assets in US: Sources

US law firm files class action lawsuit against Dr Reddy's for misleading statements

Hold Dr Reddy's Laboratories; target of Rs 2450: Axis Direct

What's In A Name? Registration of surnames as trademark

Hold Dr Reddys Laboratories: Ventura Securities

Kronos Drives Workforce Compliance And Productivity At Dr. Reddy's

Unsure of how biz will shape up in German mkt: Dr Reddy's